Profound Medical Corp. (PROF)
USD 5.0
(-6.98%)
USD 5.0
(-6.98%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -1.35 USD | 0.72% |
| 2022 | -1.38 USD | 8.0% |
| 2021 | -1.50 USD | -20.0% |
| 2020 | -1.25 USD | 10.07% |
| 2019 | -1.39 CAD | 8.55% |
| 2018 | -1.52 CAD | 37.7% |
| 2017 | -2.44 CAD | 16.72% |
| 2016 | -2.93 CAD | 41.16% |
| 2015 | -4.98 CAD | 86.85% |
| 2014 | -37.86 CAD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | -0.28 USD | -7.69% |
| 2024 Q1 | -0.25 USD | 38.1% |
| 2023 Q1 | -0.32 USD | 30.43% |
| 2023 FY | - USD | 0.72% |
| 2023 Q4 | -0.43 USD | -65.38% |
| 2023 Q3 | -0.26 USD | 25.71% |
| 2023 Q2 | -0.35 USD | -9.37% |
| 2022 Q1 | -0.40 USD | 18.37% |
| 2022 Q3 | -0.24 USD | 17.24% |
| 2022 Q4 | -0.46 USD | -91.67% |
| 2022 Q2 | -0.29 USD | 27.5% |
| 2022 FY | - USD | 8.0% |
| 2021 FY | - USD | -20.0% |
| 2021 Q1 | -0.37 USD | 0.0% |
| 2021 Q3 | -0.29 USD | 17.14% |
| 2021 Q4 | -0.49 USD | -68.97% |
| 2021 Q2 | -0.35 USD | 5.41% |
| 2020 Q1 | -0.17 CAD | 0.0% |
| 2020 Q3 | -0.32 CAD | 3.03% |
| 2020 Q4 | -0.37 USD | -15.63% |
| 2020 FY | - USD | 10.07% |
| 2020 Q2 | -0.33 CAD | -94.12% |
| 2019 Q1 | -0.20 CAD | 0.0% |
| 2019 Q4 | - CAD | 100.0% |
| 2019 Q3 | -0.43 CAD | -4.88% |
| 2019 Q2 | -0.41 CAD | -105.0% |
| 2019 FY | - CAD | 8.55% |
| 2018 Q3 | -0.37 CAD | 9.76% |
| 2018 Q1 | -0.49 CAD | 0.0% |
| 2018 FY | - CAD | 37.7% |
| 2018 Q4 | - CAD | 100.0% |
| 2018 Q2 | -0.41 CAD | 16.33% |
| 2017 Q3 | -0.72 CAD | -10.77% |
| 2017 FY | - CAD | 16.72% |
| 2017 Q4 | - CAD | 100.0% |
| 2017 Q2 | -0.65 CAD | -16.07% |
| 2017 Q1 | -0.56 CAD | 0.0% |
| 2016 Q1 | -0.77 CAD | 0.0% |
| 2016 Q3 | -0.78 CAD | -9.86% |
| 2016 Q4 | - CAD | 100.0% |
| 2016 FY | - CAD | 41.16% |
| 2016 Q2 | -0.71 CAD | 7.79% |
| 2015 Q2 | -5.42 CAD | -867.86% |
| 2015 Q1 | -0.56 CAD | 0.0% |
| 2015 Q4 | - CAD | 100.0% |
| 2015 FY | - CAD | 86.85% |
| 2015 Q3 | -0.56 CAD | 89.67% |
| 2014 Q1 | -1.55 CAD | 0.0% |
| 2014 Q4 | - CAD | 100.0% |
| 2014 FY | - CAD | 0.0% |
| 2014 Q3 | -4.13 CAD | 0.0% |